TOP NEWS

NantWorks Inks Licensing Deal With Amgen

Los Angeles-based NantPharma, one of the companies that is part of Patrick Soon-Shiong's NantWorks companies, said this morning that it has entered into a license agreement with Thousand Oaks-based Amgen. NantPharma said it has acquired exclusive rights to develop and commercialize worldwide, excluding Japan, Russia and certain other Central Asian countries, AMG 337, a compound Amgen hhas been developing for cancer therapy. Financial details of the deal were not disclosed. The license is the second between NantWorks and Amgen


LATEST HEADLINES

More Headlines

BROWSE ISSUES